/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2021-09-08 08:13:472021-09-08 08:13:47AM-Pharma and Kyowa Kirin Sign Exclusive License Agreement for Commercialization of Ilofotase Alfa in Japan
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2021-07-06 08:30:402021-07-09 08:40:25AM-Pharma Appoints Mark Altmeyer as Chairman of its Supervisory Board
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2021-07-01 12:44:002021-07-01 12:45:28AM-Pharma Enrolls First Patient in Japan for Ongoing Phase III SA-AKI Pivotal REVIVAL Trial
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2021-01-07 10:01:062021-03-02 08:43:18AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2020-11-12 09:59:162020-11-12 10:00:10AM-Pharma Announces Enrollment of the First Patient in REVIVAL Phase III Pivotal Trial in Patients with Sepsis-Associated Acute Kidney Injury
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2012-11-06 16:38:372021-01-07 12:22:31Alkaline phosphatase as a treatment for sepsis-associated acute kidney injury
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2010-05-21 17:08:562021-01-07 12:22:54The Protective Role of Intestinal Alkaline Phosphatase in Necrotizing Enterocolitis
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png00Info/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.pngInfo2009-11-02 15:47:492021-01-07 12:23:00Exogenous Alkaline Phosphatase for the Treatment of Patients with Moderate to Severe Ulcerative Colitis
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Google Analytics Cookies
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
Other external services
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
The following cookies are also needed - You can choose if you want to allow them: